Media Coverage Archive 2019

Media Coverage

Media Coverage Archive 2019

This page contains a listing of news items featuring Fred Hutch. Older items may be located in the archive to the left.

Forbes, June 11, 2019
Dr. Susan Bullman commented on a study about the gut microbiome and breast cancer.
The Los Angeles Times, June 6, 2019
Dr. Scott Ramsey, director of Fred Hutch’s health care economics and policy research group, provided expert commentary on the high cost of cancer care in the United States.
CNN, June 5, 2019
Fred Hutch Dr. Hans-Peter Kiem, director of the Stem Cell and Gene Therapy Program at Fred Hutch, provided expert commentary on a study about editing genes passed down to offspring.
STAT, June 5, 2019
Fred Hutch Dr. Hans-Peter Kiem, director of the Stem Cell and Gene Therapy Program at Fred Hutch, provided expert commentary on a study about editing genes passed down to offspring.
The Scientist, June 3, 2019
Dr. Hans-Peter Kiem provided expert commentary on a recent study showing that a genetic mutation of a gene that protects HIV infection is associated with earlier death.
United Airlines Hemispheres Magazine, June 1, 2019
United Airlines’ in-flight magazine interviewed Dr. Gary Gilliland to learn more about Fred Hutch’s work with Microsoft and Amazon to help advance cancer research.
KOMO News, May 31, 2019
Dr. Anne McTiernan shared her expertise on exercise and cancer prevention in a segment that highlighted her new exercise study.
Reader's Digest , May 29, 2019
Reader’s Digest covered Dr. Justin Taylor’s recent study in Science Immunology on B cell engineering.
OncLive, May 28, 2019
OncLive included Dr. Fred Appelbaum as one of this year’s “Giants of Cancer Care” for his leukemia work.
FierceBiotech, May 27, 2019
Fred Hutch Dr. Jennifer Adair’s recent research published in Nature Materials shows how to use a gold nanoparticle to deliver gene editing machinery to blood stem cells.
MedPage Today, May 24, 2019
Fred Hutch Dr. Elihu Estey provides expert commentary related to treatment-related mortality and treatment resistance for patients with acute myeloid leukemia (AML).
The Seattle Times, May 23, 2019
Dr. Mario Kratz provided comments on why he reviews the latest nutrition and health books for the Red Pen Reviews website.
GeekWire, May 22, 2019
GeekWire highlighted Fred Hutch’s recent developments to move into the historic Lake Union Steam Plant building.
MLB.com , May 21, 2019
MLB.com covered the news of Oakland A’s outfielder Stephen Piscotty winning the Hutch Award. The news was also published in the San Francisco Chronicle, NBC Sports Bay Area, and the San Jose Mercury News.
GeekWire, May 17, 2019
Science covered a B cell engineering study led by Dr. Justin Taylor.
King 5, May 7, 2019
King 5 highlighted Fred Hutch’s ‘Glow Orange to Cure Cancer’ campaign, a week-long campaign where Seattle landmarks and businesses glowed orange for a week in May in honor of National Cancer Research month.
Oncology Times , May 5, 2019
Dr. Allison Kaeding is featured in a profile piece for her work on pediatric acute myeloid leukemia (AML).
STAT, May 6, 2019
STAT covered Dr. Bernardo Goulart’s study on using artificial intelligence to identify certain lung cancer patients.
Survivornet, May 6, 2019
Dr. Amanda Phipps provided expert commentary on a recent study on sleep apnea and cancer risk.
GeekWire, May 6, 2019
GeekWire profiled Fred Hutch Dr. Bernardo Goulart’s recent study on using artificial intelligence to identify lung cancer patients that have certain mutations.
The Seattle Times, May 1, 2019
The Seattle Times cited Dr. Mario Kratz about the health impact of sugary beverages.
GeekWire, April 30, 2019
GeekWire covered Fred Hutch Dr. Jesse Bloom’s recent study looking at how the bird flu travels to humans.
KING 5, April 26, 2019
KING 5 aired a story on the Base 2 Space fundraising event that benefits Fred Hutch.
GeekWire, April 23, 2019
GeekWire highlighted Drs. Nancy Davidson and Denise Galloway recent induction into the Academy of Arts and Sciences, a scholarly society that began in 1780.
NPR, April 18, 2019
Dr. Veena Shankaran, co-director of Fred Hutch’s health care and economics policy research group, the Hutchinson Institute for Cancer Outcomes Research, commented on the impact of high-deductible health plans on people with cancer. She said, “high-deductible plans are really the epitome of the access-to-care problem. People don't have the liquid cash to meet their deductible, so you see delays in care or even avoiding treatment altogether.”
The Washington Post, April 14, 2019
Fred Hutch Dr. Jonathan Wright provided expert commentary on the relationship between excess weight and cancer risk. Dr. Wright is currently conducting a trial on overweight patients with low-grade, slow growing prostate cancer to see if monitoring their glucose levels through a weight loss period will improve their cancer outcomes.
Ecancer, April 15, 2019
At the American Association for Cancer Research annual meeting, Fred Hutch Dr. Yiting Lim explained the 5’ UTR mutations that are present among the DNA of prostate cancer patients.
NBC Sports Bay Area , April 9, 2019
NBC Sports Bay Area profiled the nominees for the 54th annual Hutch Awards and how the honor represents the legacy of Fred Hutchinson.
The Scientist , April 4, 2019
In this Q&A, Dr. Nancy E. Davidson, director of Fred Hutch’s Clinical Research Division and executive director and president of Seattle Cancer Care Alliance, discussed the latest breast cancer research and what has been learned so far in clinical trials for epigenetic therapies.
FierceBiotech, April 1, 2019
FierceBiotech highlighted work conducted by Dr. Kristin Anderson in Dr. Phil Greenberg’s lab on immunotherapy in ovarian cancer. The results, which were presented at the 2019 American Association for Cancer Research annual meeting showed that when combining engineered T cells with two other immune boosting treatments, the growth of ovarian tumors in mice was decreased.
American Journal of Managed Care, March 24, 2019
Fred Hutch Dr. Gary Lyman discussed the role of biosimilars and their growing use in cancer treatment.
GeekWire, March 15, 2019
Fred Hutch CIO Kathy Alexion is profiled in this feature piece as GeekWire’s ‘Working Geek’.
Crosscut, March 13, 2019
Regina Wu, who works in Fred Hutch’s Science Education Partnership program, is featured for her efforts in co-founding Seattle’s only community science lab.
KING 5, March 13, 2019
KING 5 documented Seattle Mayor Jenny Durkan’s visit to Fred Hutch to discuss the future of cancer research in Seattle.
CURE, March 8, 2019
CURE profiled Dr. Gary Lyman and a New England Journal of Medicine study he co-authored that evaluated a drug’s safety and efficacy in preventing blood clots in cancer patients. The results from this study, known as the CASSINI trial, showed that the drug may reduce the risk of blood clots in cancer patients.
NPR, March 7, 2019
Fred Hutch’s Dr. Jesse Bloom commented on a study evaluating the early development of a new antiviral drug for influenza. He said, “We need more drugs in the fight against flu, and this approach could provide them."
HealthDay, March 5, 2019
Dr. Hans-Peter Kiem, co-director of Fred Hutch’s HIV cure research program, provided insight around the second person who reportedly has been cured of HIV.
KING 5, March 5, 2019
Vishavjit Singh, a political cartoonist, performance artist and activist visited Fred Hutch to discuss how to confront biases and celebrate diversity and inclusion. This piece highlights his visit and the efforts at Fred Hutch to foster a supportive and inclusive scientific community.
Associated Press, March 5, 2019
Fred Hutch virologist Dr. Keith Jerome provided expert commentary about the second person who reportedly has been cured of HIV.
STAT, March 4, 2019
Fred Hutch virologist Dr. Keith Jerome provided context around news of the second person who reportedly has been cured of HIV. He commented, “Now there’s not one, but two people that others living with HIV can look toward for encouragement.”
KING 5, March 4, 2019
KING 5 aired multiple stories on Dr. Jonathan Bricker’s efforts to help cancer patients quit smoking and to support the Washington state tobacco 21 bill which will raise the age of smoking from 18 to 21. The bill was signed into law at Fred Hutch on April 5th.
HemOnc Today, Feb. 26, 2019
Dr. Veena Shankaran is profiled about her new role as the co-director of Hutchinson Institute for Cancer Outcomes Research.
Crosscut, Feb. 26, 2019
In this profile piece, Eric Nealy, a graduate research assistant in Dr. Jim Olson’s lab, discusses how with the help of his mom, his high school biology teacher, and the only African American science professor he could find at college helped him pursue a career in cancer research.
CURE, Feb. 25, 2019
This article features a recent study by Fred Hutch researcher Dr. Scott Ramsey published in JAMA Oncology which found that many cancer patients were had undiagnosed Hepatitis B and C and HIV infection.
Targeted Oncology, Feb. 22, 2019
Dr. Jordan Gauthier explains his findings on a combination immunotherapy treatment. Gauthier and his team found that adding the targeted therapy drug ibrutinib to CAR T-cell therapy led to improved responses in patients with relapsed/refractory chronic lymphocytic leukemia.
Healio, Feb. 21, 2019
This article features Dr. Gary Lyman’s recent research published in the New England Journal of Medicine. This was the first clinical study investigating the use of the direct oral anticoagulant, rivaroxaban, to prevent blood clots in patients with cancer at high-risk.
National Cancer Institute, Feb. 20, 2019
This blog post features Dr. Cyrus Ghajar’s latest work on metastatic breast cancer showing that dormant tumor cells can be sensitized to chemotherapy.
Targeted Oncology, Feb. 19, 2019
Dr. Victor Chow explains different treatment settings that CAR T-cell therapy is used in patients with B-cell lymphomas. He states that, “While CAR T cells have been approved for treatment of individuals after two or more lines of therapy, studies are now looking at moving this to the upfront setting.”
STAT, Feb. 19, 2019
This article notes research led by Dr. Justin Taylor using CRISPR, a gene-editing tool, to fight viruses when vaccines can’t. Taylor explained how his team has been investigating CRISPR as a tool to edit B cells in mice that could synthesize antibodies against respiratory syncytial virus (RSV).
Forbes, Feb. 19, 2019
This article features Dr. Joe Unger’s recent study on barriers to clinical trials. Unger’s study showed that structural and clinical barriers prevent more than 3 out of 4 cancer patients from participating in clinical trials.
CURE, Feb. 13, 2019
This article on new techniques to detect minimal residual disease includes expert commentary by Dr. Mary-Percival and highlights trials that are going on at Fred Hutch to examine personalized cell therapies for treating MRD in different blood cancers.
Men’s Health, Feb. 12, 2019
Dr. Keith Jerome is featured in a story of research progress in treating herpes. He explains how his work with the gene editing tool – a class of enzymes called meganucleases – is showing more success in getting rid of the virus.
Targeted Oncology , Feb. 11, 2019
Dr. Jonathan Wright discusses the available therapies for patients with localized muscle-invasive bladder cancer which include neoadjuvant chemotherapy, upfront cystectomy and immunotherapy.
GeekWire, Feb. 7, 2019
GeekWire mentioned Fred Hutch’s work with Microsoft on helping cancer patients better track their treatment side effects.
GeekWire, Feb. 4, 2019
Kathy Alexion’s new role as Fred Hutch’s CIO was announced in GeekWire’s weekly tech moves column. Alexion previously supported former CIO Matthew Trunnell since 2016.
FierceBiotech, Feb. 4, 2019
This article features recent HIV research from Fred Hutch Drs. Jesse Bloom and Julie Overbaugh. Researchers have created an atlas of immune-evading mutations HIV mutations, providing insight on the functional interactions between antibodies and HIV.
Everyday Health, Feb. 4, 2019
Fred Hutch researcher Stephen Schwartz provides expert commentary on a study published in The Lancet Public Health on obesity and cancer.
The Guardian, Feb. 3, 2019
This article features research led by Fred Hutch researcher Dr. Anne McTiernan showing that women who exercised for 45 minutes in the morning 5 days a week reported 70 percent better sleep than before the study.
KIRO 7 TV, Jan. 31, 2019
Fred Hutch Dr. Trevor Bedford comments on the value of the Seattle Flu Study.
GeekWire, Jan. 31, 2019
Dr. Veena Shankaran’s new role as the co-director of Fred Hutch’s healthcare economics and policy group was announced in GeekWire’s weekly tech moves column.
Cascadia Magazine, Jan. 30, 2019
Fred Hutch researcher Drs. Keith Jerome, Hans-Peter Kiem and Michael Louella, who coordinates the research group’s Community Advisory Board, provide expert comments on the importance of community engagement in HIV research.
Q13 Fox, Jan. 29, 2019
Fred Hutch researcher Dr. Anne McTiernan provided expert commentary on the value of exercise for those who have breast cancer.
Q13 Fox, Jan. 29, 2019
Fred Hutch researcher Dr. Anne McTiernan is featured in this segment for her research on exercise in relation to breast cancer prevention. Dr. McTiernan found that moderate exercise, 45 minutes a day, 5 days a week, can reduce breast cancer risk by as much as 20%.
Reuters Health – MD Linx, Jan. 28, 2019
This article features Fred Hutch researcher Dr. Parth Shah’s latest research on HPV vaccination. Dr. Shah found that parents were more confident in HPV vaccination and more motivated to have their child vaccinated by being exposed to physician messages that provided information rather than a sense of urgency.
POZ, Jan. 25, 2019
This article highlights a recent study which found a high rate of undiagnosed acute and chronic hepatitis among cancer patients. Fred Hutch researcher Dr. Scott Ramsey provides expert commentary on the implications the study has in terms of screening. U.S. News & World Report also covered this study.
Managed Care Online , Jan. 25, 2019
Fred Hutch researcher Dr. Gary Lyman is featured in this Q&A piece on biosimilars. Dr. Lyman provides comments about how the high prices of cancer treatment contribute to financial toxicity.
GeekWire, Jan. 23, 2019
This story features the Seattle Flu Study, a new project from the Brotman Baty Institute which was co-founded by Seattle Children’s, UW Med and Fred Hutch. The study will look at 10,000 swabs to better understand how the flu spreads and how to prevent it. Fred Hutch’s Dr. Trevor Bedford is the lead data scientist for the study.
The Seattle Times, Jan. 23, 2019
This article includes a mention of a Fred Hutch study led by Dr. Marian Neuhouser which found that women diagnosed with breast cancer who ate a low-fat diet were more likely to survive.
Forbes, Jan. 21, 2019
Dr. Cyrus Ghajar’s latest research on metastatic breast cancer is the focus of this piece. Dr. Ghajar’s work details how to kill dormant breast cancer cells in their sleep. Several other outlets including GeekWire, KOMO-TV and FireceBiotech also covered this news.
ABC News (Australia), Jan. 17, 2019
Dr. Geoffrey Hill and collaborators in Australia discovered how a common virus called cytomegalovirus reactivates in transplantation patients. In a study published in Science, the researchers found that strain-specific antibodies made from B cells are responsible for keeping CMV suppressed in mice, without the need for any other immune cells.
CURE Today, Jan. 16, 2019
This article features Dr. Joseph Unger’s recent study in JAMA Oncology on clinical trial participation. Dr. Unger shows that patients with comorbidities are less likely to participate in clinical trials.
Men’s Health, Jan. 14, 2019
This piece highlights a study published in JNCI by Fred Hutch Dr. Joseph Unger, which shows that men who’ve taken 5-alpha reductase inhibitors had a 21 percent reduced risk of PCa 16 years later.
Becker’s Hospital Review, Jan. 11, 2019
This piece features Fred Hutch Dr. Joseph Unger’s latest research showing that expanding clinical trial eligibility criteria to allow patients with comorbidities would give opportunities for up to 6,317 cancer patients to be allowed to join a trial every year.
GeekWire, Jan. 11, 2019
Fred Hutch researcher Dr. Steve Pergam is featured as GeekWire’s ‘Geek of the Week’. Dr. Pergam is an associate member of the Vaccine and Infectious Disease Division at Fred Hutch.
ecancer, Jan. 11, 2019
Fred Hutch researcher Dr. Joseph Unger’s latest research on clinical trial participation is featured in this piece. Dr. Unger and his team showed that cancer patients with other illnesses or conditions, are less likely to be offered to join a clinical trial, and therefore less likely to enroll. This research was published in several other outlets including Healio, Medical Health News and MedPage Today.
CURE Today, Jan. 5, 2019
Fred Hutch Dr. Filippo Milano in featured in this Q&A piece about how cord blood is used for transplants.